CDK inhibitor p57^Kip2 is negatively regulated by COP9 signalosome subunit 6

References

• Tomoda K, Kubota Y, Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 1999; 398:160 - 5; http://dx.doi.org/10.1038/18230; PMID: 10086358
   PubMed Web of Science ®Google Scholar
• Naumann M, Bech-Otschir D, Huang X, Ferrell K, Dubiel W. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J Biol Chem 1999; 274:35297 - 300; http://dx.doi.org/10.1074/jbc.274.50.35297; PMID: 10585392
   PubMed Web of Science ®Google Scholar
• Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C, et al. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 2001; 20:1630 - 9; http://dx.doi.org/10.1093/emboj/20.7.1630; PMID: 11285227
   PubMed Web of Science ®Google Scholar
• Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, et al. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J Clin Invest 2011; 121:851 - 65; http://dx.doi.org/10.1172/JCI44111; PMID: 21317535
   PubMed Web of Science ®Google Scholar
• Zhang XC, Chen J, Su CH, Yang HY, Lee MH. Roles for CSN5 in control of p53/MDM2 activities. J Cell Biochem 2008; 103:1219 - 30; http://dx.doi.org/10.1002/jcb.21504; PMID: 17879958
   PubMed Web of Science ®Google Scholar
• Choi HH, Gully C, Su CH, Velazquez-Torres G, Chou PC, Tseng C, et al. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ. Oncogene 2011; 30:4791 - 801; http://dx.doi.org/10.1038/onc.2011.192; PMID: 21625211
   PubMed Web of Science ®Google Scholar
• Wei N, Deng XW. The COP9 signalosome. Annu Rev Cell Dev Biol 2003; 19:261 - 86; http://dx.doi.org/10.1146/annurev.cellbio.19.111301.112449; PMID: 14570571
   PubMed Web of Science ®Google Scholar
• Lee MH, Zhao R, Phan L, Yeung SC. Roles of COP9 signalosome in cancer. Cell Cycle 2011; 10:3057 - 66; http://dx.doi.org/10.4161/cc.10.18.17320; PMID: 21876386
   PubMed Web of Science ®Google Scholar
• Karniol B, Chamovitz DA. The COP9 signalosome: from light signaling to general developmental regulation and back. Curr Opin Plant Biol 2000; 3:387 - 93; http://dx.doi.org/10.1016/S1369-5266(00)00101-1; PMID: 11019806
   PubMed Web of Science ®Google Scholar
• Li L, Deng XW. The COP9 signalosome: an alternative lid for the 26S proteasome?. Trends Cell Biol 2003; 13:507 - 9; http://dx.doi.org/10.1016/j.tcb.2003.08.002; PMID: 14507477
   PubMed Web of Science ®Google Scholar
• Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78:59 - 66; http://dx.doi.org/10.1016/0092-8674(94)90572-X; PMID: 8033212
   PubMed Web of Science ®Google Scholar
• Lee MH, Reynisdóttir I, Massagué J. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995; 9:639 - 49; http://dx.doi.org/10.1101/gad.9.6.639; PMID: 7729683
   PubMed Web of Science ®Google Scholar
• Lee MH, Yang HY. Negative regulators of cyclin-dependent kinases and their roles in cancers. Cell Mol Life Sci 2001; 58:1907 - 22; http://dx.doi.org/10.1007/PL00000826; PMID: 11766887
   PubMed Web of Science ®Google Scholar
• Yan Y, Frisén J, Lee MH, Massagué J, Barbacid M. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 1997; 11:973 - 83; http://dx.doi.org/10.1101/gad.11.8.973; PMID: 9136926
   PubMed Web of Science ®Google Scholar
• Zhang P, Liégeois NJ, Wong C, Finegold M, Hou H, Thompson JC, et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 1997; 387:151 - 8; http://dx.doi.org/10.1038/387151a0; PMID: 9144284
   PubMed Web of Science ®Google Scholar
• Lee MH, Yang HY. Regulators of G1 cyclin-dependent kinases and cancers. Cancer Metastasis Rev 2003; 22:435 - 49; http://dx.doi.org/10.1023/A:1023785332315; PMID: 12884917
   PubMed Web of Science ®Google Scholar
• Kavanagh E, Joseph B. The hallmarks of CDKN1C (p57, KIP2) in cancer. Biochim Biophys Acta 2011; 1816:50 - 6; PMID: 21447370
   PubMed Web of Science ®Google Scholar
• Guo H, Tian T, Nan KJ, Wang W. p57: A multifunctional protein in cancer (Review). [Review] Int J Oncol 2010; 36:1321 - 9; PMID: 20428755
   PubMed Web of Science ®Google Scholar
• Borriello A, Caldarelli I, Bencivenga D, Criscuolo M, Cucciolla V, Tramontano A, et al. p57(Kip2) and cancer: time for a critical appraisal. Mol Cancer Res 2011; 9:1269 - 84; http://dx.doi.org/10.1158/1541-7786.MCR-11-0220; PMID: 21816904
   PubMed Web of Science ®Google Scholar
• Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Imaki H, et al. Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc Natl Acad Sci USA 2003; 100:10231 - 6; http://dx.doi.org/10.1073/pnas.1831009100; PMID: 12925736
   PubMed Web of Science ®Google Scholar
• Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 2001; 3:973 - 82; http://dx.doi.org/10.1038/ncb1101-973; PMID: 11715018
   PubMed Web of Science ®Google Scholar
• Xue Y, Chen J, Choi HH, Phan L, Chou PC, Zhao R, et al. HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53. Cell Cycle 2012; 11:4181 - 90; http://dx.doi.org/10.4161/cc.22413; PMID: 23095642
   PubMed Web of Science ®Google Scholar
• Jin J, Ang XL, Shirogane T, Wade Harper J. Identification of substrates for F-box proteins. Methods Enzymol 2005; 399:287 - 309; http://dx.doi.org/10.1016/S0076-6879(05)99020-4; PMID: 16338364
   PubMed Web of Science ®Google Scholar
• Rinaldi T, Bolotin-Fukuhara M, Frontali L. A Saccharomyces cerevisiae gene essential for viability has been conserved in evolution. Gene 1995; 160:135 - 6; http://dx.doi.org/10.1016/0378-1119(95)00212-O; PMID: 7628709
   PubMed Web of Science ®Google Scholar
• Penney M, Wilkinson C, Wallace M, Javerzat JP, Ferrell K, Seeger M, et al. The Pad1+ gene encodes a subunit of the 26 S proteasome in fission yeast. J Biol Chem 1998; 273:23938 - 45; http://dx.doi.org/10.1074/jbc.273.37.23938; PMID: 9727008
   PubMed Web of Science ®Google Scholar
• Wei N, Deng XW. Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. Trends Genet 1999; 15:98 - 103; http://dx.doi.org/10.1016/S0168-9525(98)01670-9; PMID: 10203806
   PubMed Web of Science ®Google Scholar
• Maytal-Kivity V, Reis N, Hofmann K, Glickman MH. MPN+, a putative catalytic motif found in a subset of MPN domain proteins from eukaryotes and prokaryotes, is critical for Rpn11 function. BMC Biochem 2002; 3:28; http://dx.doi.org/10.1186/1471-2091-3-28; PMID: 12370088
   PubMed Web of Science ®Google Scholar
• Lyapina S, Cope G, Shevchenko A, Serino G, Tsuge T, Zhou C, et al. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 2001; 292:1382 - 5; http://dx.doi.org/10.1126/science.1059780; PMID: 11337588
   PubMed Web of Science ®Google Scholar
• Kim M, Nakamoto T, Nishimori S, Tanaka K, Chiba T. A new ubiquitin ligase involved in p57KIP2 proteolysis regulates osteoblast cell differentiation. EMBO Rep 2008; 9:878 - 84; http://dx.doi.org/10.1038/embor.2008.125; PMID: 18660753
   PubMed Web of Science ®Google Scholar
• Arboleda VA, Lee H, Parnaik R, Fleming A, Banerjee A, Ferraz-de-Souza B, et al. Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome. Nat Genet 2012; 44:788 - 92; http://dx.doi.org/10.1038/ng.2275; PMID: 22634751
   PubMed Web of Science ®Google Scholar
• Riccio A, Cubellis MV. Gain of function in CDKN1C. Nat Genet 2012; 44:737 - 8; http://dx.doi.org/10.1038/ng.2336; PMID: 22735584
   PubMed Web of Science ®Google Scholar
• Iyer SV, Iwakuma T. A novel link between the HER2-Akt and MDM2-p53 pathways via CSN6. Cell Cycle 2012; 11:4112; http://dx.doi.org/10.4161/cc.22606; PMID: 23099920
   PubMed Web of Science ®Google Scholar
• Yang H, Zhao R, Yang HY, Lee MH. Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity. Oncogene 2005; 24:1924 - 35; http://dx.doi.org/10.1038/sj.onc.1208352; PMID: 15688030
   PubMed Web of Science ®Google Scholar
• Reynisdóttir I, Polyak K, Iavarone A, Massagué J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 1995; 9:1831 - 45; http://dx.doi.org/10.1101/gad.9.15.1831; PMID: 7649471
   PubMed Web of Science ®Google Scholar
• Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 2004; 428:190 - 3; http://dx.doi.org/10.1038/nature02330; PMID: 15014502
   PubMed Web of Science ®Google Scholar
• Laronga C, Yang HY, Neal C, Lee MH. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 2000; 275:23106 - 12; http://dx.doi.org/10.1074/jbc.M905616199; PMID: 10767298
   PubMed Web of Science ®Google Scholar
• Yang HY, Shao R, Hung MC, Lee MH. p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis. Oncogene 2001; 20:3695 - 702; http://dx.doi.org/10.1038/sj.onc.1204472; PMID: 11439332
   PubMed Web of Science ®Google Scholar